Pogribny IP - Search Results

1

MicroRNAs as biomarkers for clinical studies.

Pogribny IP. Pogribny IP. Exp Biol Med (Maywood). 2018 Feb;243(3):283-290. doi: 10.1177/1535370217731291. Epub 2017 Sep 15. Exp Biol Med (Maywood). 2018. PMID: 28914096 Free PMC article. Review.

2

Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet.

Tryndyak VP, Latendresse JR, Montgomery B, Ross SA, Beland FA, Rusyn I, Pogribny IP. Tryndyak VP, et al. Among authors: pogribny ip. Toxicol Appl Pharmacol. 2012 Jul 1;262(1):52-9. doi: 10.1016/j.taap.2012.04.018. Epub 2012 Apr 24. Toxicol Appl Pharmacol. 2012. PMID: 22561871 Free PMC article.

3

Environmental toxicants, epigenetics, and cancer.

Pogribny IP, Rusyn I. Pogribny IP, et al. Adv Exp Med Biol. 2013;754:215-32. doi: 10.1007/978-1-4419-9967-2_11. Adv Exp Med Biol. 2013. PMID: 22956504 Free PMC article. Review.

4

Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease.

Pogribny IP, Beland FA. Pogribny IP, et al. Expert Opin Drug Metab Toxicol. 2013 Jun;9(6):713-24. doi: 10.1517/17425255.2013.783817. Epub 2013 Apr 9. Expert Opin Drug Metab Toxicol. 2013. PMID: 23565851 Review.

5

The role for microRNAs in drug toxicity and in safety assessment.

Marrone AK, Beland FA, Pogribny IP. Marrone AK, et al. Among authors: pogribny ip. Expert Opin Drug Metab Toxicol. 2015 Apr;11(4):601-11. doi: 10.1517/17425255.2015.1021687. Epub 2015 Mar 5. Expert Opin Drug Metab Toxicol. 2015. PMID: 25739314 Review.

6

The role of microRNAs in the development and progression of chemical-associated cancers.

Pogribny IP, Beland FA, Rusyn I. Pogribny IP, et al. Toxicol Appl Pharmacol. 2016 Dec 1;312:3-10. doi: 10.1016/j.taap.2015.11.013. Epub 2015 Nov 24. Toxicol Appl Pharmacol. 2016. PMID: 26621330 Review.

7

Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents.

Pogribny IP, Rusyn I, Beland FA. Pogribny IP, et al. Environ Mol Mutagen. 2008 Jan;49(1):9-15. doi: 10.1002/em.20342. Environ Mol Mutagen. 2008. PMID: 17879298 Free PMC article. Review.

8

Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet.

Tryndyak VP, Ross SA, Beland FA, Pogribny IP. Tryndyak VP, et al. Among authors: pogribny ip. Mol Carcinog. 2009 Jun;48(6):479-87. doi: 10.1002/mc.20484. Mol Carcinog. 2009. PMID: 18942116

9

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.

Pogribny IP, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI, Kovalchuk O. Pogribny IP, et al. Int J Cancer. 2010 Oct 15;127(8):1785-94. doi: 10.1002/ijc.25191. Int J Cancer. 2010. PMID: 20099276 Free article.

10

Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice.

Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, Rusyn I, Beland FA. Pogribny IP, et al. Lab Invest. 2010 Oct;90(10):1437-46. doi: 10.1038/labinvest.2010.113. Epub 2010 Jun 14. Lab Invest. 2010. PMID: 20548288 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page